Bluejay Diagnostics (BJDX) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Bluejay Diagnostics (BJDX) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.06% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 189.50% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -54.61% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -6.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | 60.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.73% |
| Dec 31, 2025 | -354,850.70% |
| Sep 30, 2025 | -3,129.95% |
| Jun 30, 2025 | -6,719.63% |
| Mar 31, 2025 | 10.10% |
| Dec 31, 2024 | 95.94% |
| Sep 30, 2024 | 98.43% |
| Jun 30, 2024 | 89.58% |
| Mar 31, 2024 | 10.72% |
| Dec 31, 2023 | 18.95% |
| Sep 30, 2023 | -1,520.55% |
| Jun 30, 2023 | -105.08% |
| Mar 31, 2023 | 13.02% |
| Dec 31, 2022 | -443.06% |
| Sep 30, 2022 | -2,040.31% |
| Jun 30, 2022 | 50.43% |
| Mar 31, 2022 | 39.05% |
| Dec 31, 2021 | 60.17% |
| Sep 30, 2021 | 45.78% |